SNY - Sanofi

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 137.76B
Enterprise value 146.37B
Trailing P/E 14.61
Forward P/E 11.70
PEG ratio (5-yr expected) 3.23
Price/sales (ttm)2.63
Price/book (mrq)1.62
Enterprise value/revenue 3.22
Enterprise value/EBITDA 10.23

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-4.12%
S&P500 52-week change 33.90%
52-week high 357.82
52-week low 336.91
50-day moving average 354.35
200-day moving average 347.03

Share statistics

Avg vol (3-month) 31.71M
Avg vol (10-day) 31.2M
Shares outstanding 52.5B
Implied shares outstanding 6N/A
Float 82.21B
% held by insiders 10.01%
% held by institutions 110.52%
Shares short (14 May 2023) 43.69M
Short ratio (14 May 2023) 42.14
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 40.15%
Shares short (prior month 13 Apr 2023) 43.59M

Dividends & splits

Forward annual dividend rate 41.9
Forward annual dividend yield 43.77%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 43.80
Payout ratio 449.84%
Dividend date 322 Jun 2023
Ex-dividend date 429 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 18.09%
Operating margin (ttm)24.43%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)46.2B
Revenue per share (ttm)18.45
Quarterly revenue growth (yoy)8.10%
Gross profit (ttm)31.7B
EBITDA 14.39B
Net income avi to common (ttm)8.36B
Diluted EPS (ttm)3.61
Quarterly earnings growth (yoy)-0.70%

Balance sheet

Total cash (mrq)12.74B
Total cash per share (mrq)5.1
Total debt (mrq)21.21B
Total debt/equity (mrq)28.23
Current ratio (mrq)N/A
Book value per share (mrq)29.85

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A